September 2, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
sanofi-aventis Japan to Merge Sanofi-Synthelabo and Aventis Pharma Japan in January
 

Tokyo, Nov 1, 2005 (JCN) - sanoif-aventis Japan announced on October 31 that the legal merger of Sanofi-Synthelabo and Aventis Pharma Japan was officially approved by the two companies.

Accordingly, the new company, sanofi-aventis K.K., will be formally inaugurated as of January 1, 2006. With this move, the sanofi-aventis Group will go on offensive in Japan, the world's second largest pharmaceutical market.

By Aki Tsukioka Contributor

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Aventis Pharma Ltd. News  
  Sanofi-aventis Acquires Production and Sales Rights to Antiplatelet Agent Plavix from Daiichi Pharmaceutical  (Mar 1, 2006)
  sanofi-aventis Japan to Merge Sanofi-Synthelabo and Aventis Pharma Japan in January  (Nov 1, 2005)
  Daiichi Pharmaceutical to Transfer All Commercial Rights for Plavix to Sanofi-Aventis Japan  (July 6, 2005)
  Aventis Pharma Opened Website for Allergy Sufferers  (June 4, 2004)
  Aventis Pharma and Fujisawa to Cooperate in the Marketing of Synercid(R) Injection  (Apr 19, 2002)
  Aventis Pharma Ltd. and Eisai Announce Co-promotion agreement for the Osteoporosis Therapeutic Agent Actonel  (Mar 20, 2002)
  Fujisawa will Tie-up with Aventis Pharma for the Sales of Targocid (R) Injection, A Glycopeptide Antibiotic in Japan  (Nov 14, 2001)
  Fujisawa Exercises An Option to Acquire Rights to Malononitrilamides from Aventis Pharma  (July 10, 2001)


 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)